These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4129869)

  • 21. Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking.
    Vestal RE; Norris AH; Tobin JD; Cohen BH; Shock NW; Andres R
    Clin Pharmacol Ther; 1975 Oct; 18(4):425-32. PubMed ID: 1164824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proceedings: Drug disposition during development.
    Morselli PL
    Acta Pharm Suec; 1974 Dec; 11(6):647. PubMed ID: 1136799
    [No Abstract]   [Full Text] [Related]  

  • 23. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 24. Relationship between distribution, elimination and anticoagulant action of dicumarol.
    Jähnchen E; Levy G
    J Pharmacol Exp Ther; 1974 Feb; 188(2):293-9. PubMed ID: 4129954
    [No Abstract]   [Full Text] [Related]  

  • 25. Metabolic side-effects of allopurinol.
    O'Sullivan WJ
    Prog Biochem Pharmacol; 1974; 9():174-93. PubMed ID: 4140532
    [No Abstract]   [Full Text] [Related]  

  • 26. [Modification of the action of drugs by inhibition of their metabolism].
    Park BK; Breckenridge AM; Ohnhaus EE
    Recenti Prog Med; 1979 Sep; 67(3):313-45. PubMed ID: 42953
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
    Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ascorbic acid and drug metabolism in cynomologus monkeys.
    Green M; Turnbull J; Sauberlich H; Omaye S
    Proc West Pharmacol Soc; 1978; 21():341-4. PubMed ID: 99749
    [No Abstract]   [Full Text] [Related]  

  • 29. Interindividual differences in pharmacokinetics in man: clinical importance.
    Sjöqvist F
    Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hypothyroidism and hyperthyroidism on dipyrone metabolism in man.
    Brunk SF; Combs SP; Miller JD; Delle M; Wilson WR
    J Clin Pharmacol; 1974; 14(5-6):271-9. PubMed ID: 4364273
    [No Abstract]   [Full Text] [Related]  

  • 32. Polygenic factors controlling drug response.
    Vesell ES
    Med Clin North Am; 1974 Sep; 58(5):951-63. PubMed ID: 4138463
    [No Abstract]   [Full Text] [Related]  

  • 33. Prazepam metabolism after chronic administration to humans.
    Viau JP; Epps JE; Di Carlo J
    Xenobiotica; 1973 Sep; 3(9):581-7. PubMed ID: 4763144
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of environmental chemical agents on drug metabolism in man].
    Puzyńska L
    Pol Tyg Lek; 1980 Apr; 35(14):509-12. PubMed ID: 6773039
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.
    Sellers EM; Frecker RC; Romach MK
    Drug Metab Rev; 1983; 14(2):225-50. PubMed ID: 6341026
    [No Abstract]   [Full Text] [Related]  

  • 36. Tetrahydrocannabinol metabolism in man.
    Lemberger L
    Drug Metab Dispos; 1973; 1(1):461-8. PubMed ID: 4149419
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on the biliary excretion of 14C-dicumarol in the rat.
    Husain S; Eisenbrandt LL; Wosilait WD
    Drug Metab Dispos; 1973; 1(2):523-9. PubMed ID: 4132217
    [No Abstract]   [Full Text] [Related]  

  • 38. Microsomal enzyme induction by drugs.
    Conney AH
    Pharmacol Physicians; 1969 Dec; 3(12):1-5. PubMed ID: 4187011
    [No Abstract]   [Full Text] [Related]  

  • 39. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug interactions due to enzymatic inhibition. The predictive value of pharmacokinetic studies].
    Descotes J; Simonet R; Loupi E; Evreux JC
    Therapie; 1986; 41(5):349-51. PubMed ID: 3810522
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.